prof. dr. Ken Bracke
- ORCID iD
-
0000-0001-5906-4605
Show
Sort by
-
- Journal Article
- A1
- open access
Evaluating β2-agonists as siRNA delivery adjuvants for pulmonary surfactant-coated nanogel inhalation therapy
-
- Journal Article
- A1
- open access
Selective replacement of cholesterol with cationic amphiphilic drugs enables the design of lipid nanoparticles with improved RNA delivery
-
- Journal Article
- A1
- open access
Retrospective study shows that serum levels of chemokine CXCL10 and cytokine GDF15 support a diagnosis of sporadic inclusion body myositis and immune-mediated necrotizing myopathy
-
- Journal Article
- A1
- open access
Commensal bacteria of the lung microbiota synergistically inhibit inflammation in a three-dimensional epithelial cell model
-
- Journal Article
- A1
- open access
RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD
-
- Journal Article
- A1
- open access
The arginine methyltransferase PRMT7 promotes extravasation of monocytes resulting in tissue injury in COPD
-
- Journal Article
- A1
- open access
Adverse roles of mast cell chymase-1 in chronic obstructive pulmonary disease
-
- Journal Article
- A1
- open access
IL-10 producing regulatory B cells are decreased in blood from smokers and COPD patients
-
- Journal Article
- A1
- open access
Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies
-
- Journal Article
- A2
- open access
An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis